The following information is missing from the Funding section: This research was supported by a National Institutes of Health (NIH) grant, 3R01CA165076-03S2, Research Supplement to Promote Diversity in Health-Related Research, to Hassan M. Shaleh.
Reference
- 1. Nakamura I, Zakharia K, Banini BA, Mikhail DS, Kim TH, Yang JD, et al. (2014) Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling. PLoS ONE 9(4): e92273 doi:10.1371/journal.pone.0092273 [DOI] [PMC free article] [PubMed] [Google Scholar]